Biolexis Therapeutics CSO invited to present company MolecuLern™ technology at 2023 Annual San Antonio Drug Discovery Symposium held at Greehey Children’s Cancer Research Institute of University of Texas Health San Antonio.
https://research.utsa.edu/events/2023/04/03-cidd-annual-drug-discovery-symposium.html
April 14-19, 2023 Biolexis management participates and presents at the AACR (American Association of Cancer Research) Annual Meeting on April 14-19, 2023 – Orange County Convention Center, Orlando, Florida. ...
April 8-13, 2023 Biolexis management participated and presented pre-clinical data on CDK9 inhibitor at the AACR (American Association of Cancer Research) Annual Meeting on April 8-13, 2022, Ernest N. Morial Convention Center New Orleans, Louisiana. B137 / 13 -...
February 22-23, 2023 Biolexis Therapeutics Business Development team participated 2nd Next Generation Kinase Inhibitors Summit was held on February 22-23, 2023, in Boston.